NCT03625882View on ClinicalTrials.gov

Survey Study for Velaglucerase Alfa (VPRIV) in Japan

CompletedOBSERVATIONAL
Enrollment

63

Participants

Timeline

Start Date

September 2, 2014

Primary Completion Date

May 14, 2024

Study Completion Date

May 14, 2024

Conditions
Gaucher Disease
Trial Locations (35)

483-8704

Konan, Kōnan

453-0801

Nagoya, Nagoya

802-0803

Kitakyushu, Kitakyushu

830-0011

Kurume, Kurume

721-0927

Fukuyama, Fukuyama

739-0041

Higashihiroshima, Higashihiroshima

080-0016

Obihiro, Obihiro

252-0375

Sagamihara, Sagamihara

980-8574

Sendai, Sendai

565-0871

Suita, Suita

584-0000

Tondabayashi, Tondabayashi

350-8550

Kawagoe, Kawagoe

359-8513

Tokorozawa, Tokorozawa

524-0022

Moriyama, Moriyama

520-2192

Otsu, Ōtsu

690-0864

Matsue, Matsue

431-3125

Hamamatsu, Hamamatsu

434-8511

Hamamatsu, Hamamatsu

438-0002

Iwata, Iwata

105-8471

Minato, Minato

130-0005

Sumida-ku, Sumida-ku

683-8504

Yonago, Yonago

266-0007

Chiba, Chiba

500-8212

Gifu, Gifu

730-0046

Hiroshima, Hiroshima

734-0037

Hiroshima, Hiroshima

892-0853

Kagoshima, Kagoshima

860-8556

Kumamoto, Kumamoto

606-8507

Kyoto, Kyoto

701-1192

Okayama, Okayama

534-0021

Osaka, Osaka

545-8586

Osaka, Osaka

553-0003

Osaka, Osaka

339-8551

Saitama, Saitama

420-8688

Shizuoka, Shizuoka

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY